Equities Analysts Issue Forecasts for ARTV FY2025 Earnings
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Free Report) – Investment analysts at Cantor Fitzgerald cut their FY2025 EPS estimates for Artiva Biotherapeutics in a research report issued on Tuesday, March 25th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company will post earnings of ($2.91) per share for the year, down from their prior estimate […]
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Free Report) – Investment analysts at Cantor Fitzgerald cut their FY2025 EPS estimates for Artiva Biotherapeutics in a research report issued on Tuesday, March 25th. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company will post earnings of ($2.91) per share for the year, down from their prior estimate […]
